In “Profit over Patients: How the Rules of Our Economy Encourage the Pharmaceutical Industry’s Extractive Behavior”—the first issue brief in a series—Roosevelt Fellow Katy Milani and Advocacy and Policy Associate Devin Duffy explore the rules that govern the pharma industry and how these rules, as they are currently written, create drug companies that value profits more than people. Life and health should not be for sale but equally available to all, and policymakers have the tools necessary to rewrite the rules of our economy and ensure that drug companies put public health before profits.